Senti Biosciences Inc. (SNTI) Stock Volatility: Beta and Market Fluctuations

As of close of business last night, Senti Biosciences Inc.’s stock clocked out at $0.38, down -3.31% from its previous closing price of $0.39. In other words, the price has decreased by -$0.0129 from its previous closing price. On the day, 104006 shares were traded.

Ratios:

To gain a deeper understanding of SNTI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.62 and its Current Ratio is at 5.62. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.50.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on October 07, 2022, initiated with a Equal-Weight rating and assigned the stock a target price of $7.50.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNTI now has a Market Capitalization of 17.31M and an Enterprise Value of 19.05M. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.74 while its Price-to-Book (P/B) ratio in mrq is 0.26. Its current Enterprise Value per Revenue stands at 9.63 whereas that against EBITDA is -0.31.

Stock Price History:

Over the past 52 weeks, SNTI has reached a high of $1.26, while it has fallen to a 52-week low of $0.27. The 50-Day Moving Average of the stock is 0.4232, while the 200-Day Moving Average is calculated to be 0.5365.

Shares Statistics:

It appears that SNTI traded 152.05K shares on average per day over the past three months and 91.7k shares per day over the past ten days. A total of 45.70M shares are outstanding, with a floating share count of 26.88M. Insiders hold about 41.25% of the company’s shares, while institutions hold 9.40% stake in the company. Shares short for SNTI as of Mar 15, 2024 were 223.18k with a Short Ratio of 1.47, compared to 345.38k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.50% and a Short% of Float of 0.76%.

Earnings Estimates

As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.23 for the current quarter, with a high estimate of -$0.23 and a low estimate of -$0.23, while EPS last year was -$0.42. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is -$0.75, with 2 analysts recommending between -$0.51 and -$1.

Revenue Estimates

A total of 1 analysts have provided revenue estimates for SNTI’s current fiscal year. The highest revenue estimate was $3.46M, while the lowest revenue estimate was $3.46M, resulting in an average revenue estimate of $2.56M. In the same quarter a year ago, actual revenue was $4.29M, down -40.20% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $8.9M in the next fiscal year. The high estimate is $14M and the low estimate is $3.8M. The average revenue growth estimate for next year is up 247.50% from the average revenue estimate for this year.

Most Popular